Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...

Can you really eat or drink your way to better sleep? It would certainly be a simple solution for the one in five Britons ...

DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable ...

In a visit to UB, the lawmakers said cutting indirect cost reimbursement for grants would negatively impact livesaving ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

N.Y., decried the cuts as illegal and rooted in a willful misunderstanding of how medical research is conducted at ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...